Inhibition of PCSK9 enhances the expression of major histocompatibility complex class I (MHC I) proteins on tumor cell surfaces, facilitating significant intratumoral infiltration of cytotoxic T lymphocytes [163]. The gene discussed is PCSK9; the disease is neoplasm.